Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation
Propranolol inhibits HUVECs migration. By wound healing assay, the mobility of different concentrations (30, 60, 90, and 120 μM) of propranolol on HUVECs (a) and VEGF-induced HUVECs (b) was measured. (c) Quantitative mobility analysis. Magnification, 200x; vs. NC group; ## vs. VEGF group.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.